Literature DB >> 32306926

A case report of optic neuropathy following dacryocystorhinostomy in a 57-year-old female patient with May-Hegglin anomaly.

Seung Uk Lee1, Hyoun Do Huh2, Hyun Kyung Cho2, Su Jin Kim3,4.   

Abstract

BACKGROUND: We report a rare case of optic neuropathy following dacryocystorhinostomy (DCR) in a 57-year-old female patient with May-Hegglin anomaly. CASE
PRESENTATION: The patient was presented with sudden onset of vision loss for the left eye after DCR under general anesthesia. Her best corrected visual acuity was light perception in the left eye. Relative afferent pupillary defect was detected in her left eye. Magnetic resonance imaging of the orbit revealed an hyperintensity at the intra-orbital segment of the left optic nerve on T2-weighted image and Flair image. The patient was diagnosed with acute postoperative optic neuropathy and treated with methylprednisolone. Although her vision partially improved, she was left with a visual field defect in the left eye.
CONCLUSIONS: In patients with hematologic diseases, postoperative vision loss can occur following even minor surgery under general anesthesia, such as DCR. Therefore, preoperative counseling regarding the risk of visual loss should be given to high-risk patients.

Entities:  

Keywords:  Dacryocystorhinostomy; May-Hegglin anomaly; Optic neuropathy

Mesh:

Year:  2020        PMID: 32306926      PMCID: PMC7168880          DOI: 10.1186/s12886-020-01433-w

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


Background

We report a rare case of an optic neuropathy following dacryocystorhinostomy (DCR) in a 57-year-old female patient with May-Hegglin anomaly. Generally speaking, a DCR surgery is a very common and safe procedure that is conducted successfully throughout the world. In its positive context, a DCR can improve the subjective symptoms and the quality of life of patients with nasolacrimal duct obstructions [1]. However, it is noted that rare complications can occur, including hemorrhage, infection, cerebrospinal fluid leakage, and damage to the medial rectus or superior oblique muscle [2]. Ischemic optic neuropathy (ION) has been documented after a non-complex cataract surgery, uncomplicated pars plana vitrectomy (PPV), and non-ocular surgery, such as with a spinal or cardiac surgery [3-6]. The retinal arterial occlusion (RAO), cortical blindness, acute glaucoma, and choroidal and vitreous hemorrhage have been reported as causes of perioperative vision loss (POVL) after a non-ophthalmic surgery [7-10]. However, the instance of an optic neuropathy following DCR has not yet been reported. Here we report a case of acute postoperative optic neuropathy following DCR in a patient previously diagnosed with May-Hegglin anomaly (MHA).

Case presentation

A 57-year-old female presented with vision loss in the left eye during the restoration of consciousness after endoscopic DCR surgery for the left eye. In this case, the DCR surgery was performed under general anesthesia. Notably, 2 ml of 1% lidocaine with 1:100,000 epinephrine was injected into the axilla of the middle turbinate and the frontal process of the maxilla using a dental syringe. In this case, the neurosurgical patties soaked in 2 ml of 1:1000 epinephrine were inserted between the inferior turbinate and the nasal septum and in the middle meatus to achieve topical decongestion. In the process of making mucosal flap and incision, the patient had a higher bleeding tendency than was noted with other patients, and a suction diathermy was used meticulously for the incidence of hemostasis. For this reason, it did not lead to a major bleeding in this case. The patient’s medical history was notable for thrombocytopenia and MHA. Upon review, the patient denied temporal headache, pain, or flashes. When tested, the patient’s best-corrected visual acuity (BCVA) was 20/20 in the right eye and light perception in the left eye. Her intraocular pressure (IOP) was 14 mmHg in the right eye and 16 mmHg in the left eye. Her visual field test result was normal for the right eye. However, the test could not be conducted for the left eye due to the incidence of poor vision. When tested with the swinging flashlight maneuver, a relative afferent pupillary defect was found in the left eye of the patient. Her extraocular movements were noted as being full and painless. However, mild periorbital bruising and swelling were detected in the left eye. Additionally, there was mild maxillary sinusitis noted as well. However, it was shown there was no underlying disease in the other sinuses. On the funduscopic examination, there were no obvious abnormal findings in the macula of either eye. The use of a fluorescent angiography did not reveal leakage or a filling defect at the disc. The baseline testing included blood tests to evaluate syphilis, systemic lupus erythematosus, and neuromyelitis optica. Her erythrocyte sedimentation rate and C-reactive protein results were noted as normal. Her pre-operative platelet count was 61 × 103/mm3. A chest x-ray was performed to evaluate sarcoidosis. She was transfused with six units of platelets preoperatively, which increased her platelet count to 123 × 103/mm3. No other cause of optic neuropathy was found in this evaluation. The pattern visual evoked potential revealed delayed P100 latency (Fig. 1). Her electroretinogram showed normal electrical activity in the retina. The magnetic resonance imaging (MRI) of the orbit revealed a focal hyperintensity within the intra-orbital segment of the left optic nerve on the T2-weighted image (T2-WI) and flair image. At evaluation, the MRI showed an enhancement on the T1 post-contrast imaging (Fig. 2). It did not show any demyelinating disease in the brain. The patient was diagnosed with left optic neuropathy and treated with 1 g/day of intravenous methylprednisolone for 3 days, followed by 1 mg/kg/day of oral prednisone with subsequent dose tapering. It is noted that the patient’s BCVA improved to 20/30 after the treatment. Although her vision improved, she was left with a visual field defect in the left eye.
Fig. 1

Pattern visual evoked potential (VEP) revealing delay of P100 latency and decreased amplitude

Fig. 2

Axial images of brain MRI (a, b and c: T2-weighted image (T2-WI), Flair images, and T1 post contrast images, respectively). Coronal images of brain MRI (d, e and f: T2-WI, Flair images, and T1 post contrast images, respectively). T2-WI (d) revealing hyperintensity in the intra-orbital segment of the left optic nerve (arrow). T1 post contrast images (f) revealing enhancement in the same level (arrow)

Pattern visual evoked potential (VEP) revealing delay of P100 latency and decreased amplitude Axial images of brain MRI (a, b and c: T2-weighted image (T2-WI), Flair images, and T1 post contrast images, respectively). Coronal images of brain MRI (d, e and f: T2-WI, Flair images, and T1 post contrast images, respectively). T2-WI (d) revealing hyperintensity in the intra-orbital segment of the left optic nerve (arrow). T1 post contrast images (f) revealing enhancement in the same level (arrow)

Discussion and conclusions

Perioperative vision loss (POVL) is a rare but devastating consequence of ocular or non-ocular surgery. To this end, the nonarteritic anterior ischemic optic neuropathy (NAION) after cataract surgery or PPV has been reported to result from increased intraocular pressure (IOP), raised intra-orbital pressure from a retrobulbar anesthetic, face-down position, systemic peri-operative hypotension, or a combination of these factors [3, 4, 11, 12]. For this reason, the causes of visual impairment in patients undergoing non-ocular surgery under general anesthesia can be categorized into three main types: ION, retinal vascular occlusion, and cortical vision loss due to a perioperative stroke. The particularly high incidence of ION after coronary artery bypass grafts might be due to an increased blood viscosity caused by induced hypothermia, leading to a watershed injury to the optic nerve head [13-15]. The IOP may also play a role in these cases, because IOP spikes have been demonstrated when bypass circulation begins and the IOP may remain elevated for days after surgery. ION following spinal fusion is most commonly associated with posterior ischemic optic neuropathy (PION) [5]. Ischemia in PION involves the portion of the optic nerve perfused by the small vessels of a pial capillary plexus between the orbital apex posteriorly and the point at which the central retinal artery enters the nerve at its mid-point. As noted, prone positioning can decrease venous outflow by increasing intra-abdominal and intrathoracic pressure, raise IOP, and decrease perfusion pressure of the optic nerve head [16]. In the present case, the patient was diagnosed with MHA, a rare hematological disorder. MHA is characterized by various degrees of thrombocytopenia, giant platelets, and basophilic, cytoplasmic inclusion bodies in the granulocytes [17, 18]. Here, thrombocytopenia occurs in approximately 50% of the patients with MHA. Likewise, the clinical manifestations vary and range from mild bleeding not requiring specific treatment to severe bleeding episodes following trauma or surgery that require the administration of blood products [17, 18]. To the author’s knowledge, there are no guidelines for preoperative prophylaxis in MHA patients. In general, a platelet count of ≥50 × 109/L is recommended for safe procedures [18]. The present patient experienced neither spontaneous hemorrhage nor other complications before. She was transfused with platelets before the DCR surgery to prevent complications which were associated with bleeding. The possible differential diagnoses of this patient included traumatic optic neuropathy, compressive optic neuropathy, inflammatory optic neuropathy, anterior ischemic optic neuropathy (AION), and PION. During the surgery, there was more bleeding tendency than expected, but hemostasis was well done, in order that there was not much bleeding and there were no other problems noted. Since the pupillary reaction was observed during operation, we could rule out direct trauma to the optic nerve by needle. Additionally, as the IOP may be elevated as the injected local anesthetic material passes to the retrobulbar area, or retrobulbar bleeding occurs by needle injury, or the eyeball was pressed inadvertently by the surgeon or assistant, this may play a factor or a role in the occurring AION. However, on funduscopic examination, there was no optic disc edema or peripapillary hemorrhage. The patient’s visual acuity was improved with methylprednisolone. Thus, the possibility of an ION is low. The optic nerve may have been damaged by adrenaline-induced vasospasm, but this is less likely because the concentration and amount of adrenaline were used the same as usual surgery. Bleeding during surgery might have temporarily resulted in hypoperfusion and ischemia to the optic nerve head. Also, the existence of a PION due to hypotension seems to be the most likely cause of this event. In this case, despite pre-operative platelet transfusion and uncomplicated surgery, the patient developed vision loss, presumably due to posterior ischemic optic neuropathy. Her underlying hematologic abnormality might have increased the risk of bleeding and caused optic neuropathy. In patients with hematologic diseases, postoperative vision loss can occur following even minor surgery under general anesthesia, such as a DCR. Therefore, preoperative counseling regarding the risk of POVL should be given to high-risk patients, and appropriate prevention should be conducted to minimize the advent of any unanticipated events that can cause devastating visual morbidity.
  17 in total

1.  Posterior ischemic optic neuropathy after uncomplicated cataract extraction.

Authors:  L E Luscavage; N J Volpe; R Liss
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

2.  Post-Cataract Surgery Optic Neuropathy: Prevalence, Incidence, Temporal Relationship, and Fellow Eye Involvement.

Authors:  Ahmadreza Moradi; Sivashakthi Kanagalingam; Marie Diener-West; Neil R Miller
Journal:  Am J Ophthalmol       Date:  2016-10-27       Impact factor: 5.258

3.  Nonarteritic anterior ischemic optic neuropathy following pars plana vitrectomy for macular hole treatment: case report.

Authors:  Leonardo Provetti Cunha; Luciana Virgínia Ferreira Costa Cunha; Carolina Ferreira Costa; Mário Luiz Ribeiro Monteiro
Journal:  Arq Bras Oftalmol       Date:  2016 Sep-Oct       Impact factor: 0.872

4.  Risk factors for ischemic optic neuropathy after cardiopulmonary bypass: a matched case/control study.

Authors:  G A Nuttall; J A Garrity; J A Dearani; M D Abel; D R Schroeder; C J Mullany
Journal:  Anesth Analg       Date:  2001-12       Impact factor: 5.108

5.  The American Society of Anesthesiologists Postoperative Visual Loss Registry: analysis of 93 spine surgery cases with postoperative visual loss.

Authors:  Lorri A Lee; Steven Roth; Karen L Posner; Frederick W Cheney; Robert A Caplan; Nancy J Newman; Karen B Domino
Journal:  Anesthesiology       Date:  2006-10       Impact factor: 7.892

6.  Perioperative visual loss in ocular and nonocular surgery.

Authors:  Kathleen T Berg; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2010-06-24

Review 7.  MYH9-related platelet disorders.

Authors:  Karina Althaus; Andreas Greinacher
Journal:  Semin Thromb Hemost       Date:  2009-04-30       Impact factor: 4.180

8.  Perioperative Visual Loss in Spine Fusion Surgery: Ischemic Optic Neuropathy in the United States from 1998 to 2012 in the Nationwide Inpatient Sample.

Authors:  Daniel S Rubin; Isaac Parakati; Lorri A Lee; Heather E Moss; Charlotte E Joslin; Steven Roth
Journal:  Anesthesiology       Date:  2016-09       Impact factor: 7.892

Review 9.  Management of Acute Retinal Ischemia: Follow the Guidelines!

Authors:  Valérie Biousse; Fadi Nahab; Nancy J Newman
Journal:  Ophthalmology       Date:  2018-04-30       Impact factor: 12.079

10.  Perioperative ischemic optic neuropathy: a case control analysis of 126,666 surgical procedures at a single institution.

Authors:  Sarah E Holy; Jonathan H Tsai; Russell K McAllister; Kyle H Smith
Journal:  Anesthesiology       Date:  2009-02       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.